SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012982
Filing Date
2022-08-10
Accepted
2022-08-10 07:15:44
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20220630x10q.htm   iXBRL 10-Q 1084280
2 EX-31.1 zyne-20220630xex31d1.htm EX-31.1 11478
3 EX-31.2 zyne-20220630xex31d2.htm EX-31.2 11215
4 EX-32.1 zyne-20220630xex32d1.htm EX-32.1 6119
5 EX-32.2 zyne-20220630xex32d2.htm EX-32.2 6140
6 GRAPHIC zyne-20220630x10q001.jpg GRAPHIC 57582
  Complete submission text file 0001558370-22-012982.txt   5298108

Data Files

Seq Description Document Type Size
7 EX-101.SCH zyne-20220630.xsd EX-101.SCH 40552
8 EX-101.CAL zyne-20220630_cal.xml EX-101.CAL 42586
9 EX-101.DEF zyne-20220630_def.xml EX-101.DEF 163562
10 EX-101.LAB zyne-20220630_lab.xml EX-101.LAB 321222
11 EX-101.PRE zyne-20220630_pre.xml EX-101.PRE 271343
55 EXTRACTED XBRL INSTANCE DOCUMENT zyne-20220630x10q_htm.xml XML 947648
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 221150393
SIC: 2834 Pharmaceutical Preparations